Home | Articles
Published on:November 2021
Indian Journal of Pharmaceutical Education and Research, 2021; 55(4):1060-1065
Original Article | doi:10.5530/ijper.55.4.206

Influence of Telmisartan on Pharmacodynamic and Pharmacokinetic Properties of Glimepiridemetformin Combination Using Rodent and Non-Rodent Models


Authors and affiliation (s):

Beere Nagaraju*, Anilkumar KV

Department of Pharmacology, Visveswarapura Institute of Pharmaceutical Sciences, Bengaluru, Karnataka, INDIA

Abstract:

Aim: The present study was planned to evaluate the pharmacodynamic and pharmacokinetic interactions between telmisartan and glimepiride + metformin in single and multiple dose studies using rats and rabbits. Materials and Methods: The blood samples were collected from the rats/ rabbits from retro orbital/ marginal ear vein respectively. The serum glucose, plasma insulin and serum glimepiride were estimated at respective time intervals in all treatment groups. Results: The single and multiple dose treatments of telmisartan alone and combined treatment with glimiperide + metformin does not showed any significant reduction of glucose and elevated insulin levels in normal and diabetic rats and showed synergistic hypoglycemic activity by enhancing blood glucose reduction and peak insulin levels in normal rabbits. The serum glimepiride levels were found to be enhanced with telmisartan single and multiple dose treatments. There is significant increase in the pharmacokinetic parameters of glimepiride like AUC0-, AUMC0-t, AUMC0-∞, t1/2, Cmax and MRT and there is a decrease in clearance (Cl) with single and multiple dose treatments of telmisartan. Conclusion: The interactions observed in rabbits (a non rodent model) but not in rats (a rodent model). Hence care must be taken while prescribing telmisartan in combination with glimipiride-metformin.

Key words: Telmisartan, Glimepiride, Metformin, Pharmacokinetics, Pharmacodynamics.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the Latest Release of Journal Citation Reports (source: Web of Science Data).

 

Impact Factor® as reported in the 2023 Journal Citation Reports® (Clarivate Analytics, 2023): 0.8

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs